Is epinephrine-induced platelet aggregation autoregulated by its metabolic degradation products in vivo?

In Vivo

Volumn 12, Issue 3, 1998, Pages 321-325

  Evangelou, Angelos M ^a,b   Malamas, Mihail Ph ^a   Vezyraki, Patra ^a   Karkabounas, Spiros Ch ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

^b UNIVERSITY OF IOANNINA   (Greece)

Author keywords

ADP; Epinephrine; Lipoxygenase; Metanephrine; Methoxyphenolic derivatives; Platelet aggregation; Regulation; VMA

Indexed keywords

ADENOSINE DIPHOSPHATE; ADRENALIN; CALCIUM ANTAGONIST; CATECHOLAMINE DERIVATIVE; LIPOXYGENASE; METADRENALIN; PHENOL DERIVATIVE; SCAVENGER; VANILMANDELIC ACID;

ANIMAL CELL; ARTICLE; CATECHOLAMINE METABOLISM; CONTROLLED STUDY; DRUG DEGRADATION; EXERCISE; HUMAN; HUMAN CELL; NONHUMAN; SMOKING; STRESS; THROMBOCYTE AGGREGATION;

EID: 0031871730     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Bygdeman S and Johnsen Q: Studies of the effect of adrenergic blocking drugs on catecholamine-induced platelet aggregation and uptake of noradrenaline and 5-hydroxytyptamin. Acta Physiol Scand 75: 129-138, 1969.
2. Ardlie NG Cameron HA and Garrett J: Platelet activation by circulating levels of hormones; a possible link in coronary heart disease. Thromb Res 36: 315-322, 1984.
3. Cameron HA and Ardlie NG: The facilitaing effects of adrenaline on platelet aggregation. Prostagl Leukot Med 9: 117-128, 1982.
4. Lanza F and Cazenave J-P: Studies of alpha2-adrenergic receptors of intact and functional washed human platelets by binding of 3H-dihydroergocryptine and 3H-yohimbine. Correlation of 3H-yohimbine binding with potentiation by adrenaline of ADP-induced platelet aggregation. Thromb Haemostasis 54: 402-408, 1985.
5. Fourque F and Vargaftig BB. Triggering by PAF-acether and adrenaline of cycloxygenase-independent platelet aggregation. Br J Pharmacol 83: 625-633, 1984.
6. Makris PE, Papadopoulos A, Tsakiris DA: Lipoxygenase products changes in "in vitro" aspirinated platelets under the influence of PAF and epinephrine. Thromb Haemostasis (abstr) 58: 548, 1987.
7. Siess W, Lorenz R, Roth P and Weber PC: Plasma catecholamines, platelet aggregation and associated thromboxane formation after physiological exercise,smoking or norepinephrine infusion. Circulation 66: 44-48, 1982.
8. Siess W: Molecular mechanisms of platelet activation. Physiol Rev 69: 58-178, 1989.
9. Benvensite J, Henson PM and Cohrane CG: Leucocyte-depended histamine release from rabbit platelets.The role of basophils, IgE and a Platelet Activating Factor. .I Exp Med 136: 1356-1377, 1972.
10. Kemal C, Flamberg PL, Krupinski-Olsen R and Shorter AL: Selective inactivation of soybean lipoxygenase-1 by catecholes:A possible mechanism for regulation of lipoxygenase activity. Biochemistry 26: 7064-7072, 1987.
11. Legarde M: Roles of cycloxygenase and lipoxygenase metabolites in platelets. In: Platelets in Biolgy and Pathology. (McIntyre DE, Gordon IE, eds) Amsterdam, Elsevier Publ 1987, pp.269-288.
12. Nelson JM, Seltz SP and Cowling RA: Enzyme-bound pentadienyl and peroxyl radicals in purple lipoxygenase. Biochem 29: 6897-6903, 1990.
13. Karkabounas S, Sofis G and Evangelou A: Implication of free radicals for platelet aggregation. Antiplatelet effects of free radical scavengers ex vivo. Rev Clin Pharmacol Pharmakocin 10: 5-15, 1996.
14. Guarnier C and Muscari C: Antioxy-radical properties of trimetazidine. Res Commun Chem Pathol Pharmacol 64: 1135-1145, 1989.
15. Maridoneau-Parini I and Harpey C: Effect of trimetazidine on membrane damage induced by free radicals in human red cells. Br J Clin Pharmacol 20: 148-151, 1985.
16. Astarie-Dequeker C Joulin Y and Devynck M-A: Inhibitory effects of trimetazidine on thrombin-induced aggregation and calium entry into human platelets. J Cardiovasc Pharmacol 23: 401-407, 1994.
17. Konishi S: In vitro studies on the antiplatelet function of trimetazidine. J Tokyo Med Coll 41: 447-453, 1983.
18. Kotsis N: Studies on the mechanisms of inhibition of platelet aggregation by methoxyphernolic derivatives,with emphasis on trimetazidine. Thesis. Lab. Exp. Physiology, Faculty of Medicine Univ. of Ioannina 1996, pp.1-170.
19. Honore E, Adamantidis MM, Challice LE and Dupuis BA: Cardioprotection by calcium antagonists, piridoxilate and trimetazidine. ICRS Med Sci 14: 938-939, 1986.
20. Brodde OE and Bock KD: Changes in platelet alpha2-adrenoreceptors in human phaeochromocytoma. J Clin Pharmacol 26: 265-267, 1984.